HH
ALXN

Hilltop Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Hilltop Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,331
Closed -$208K – 227
2014
Q2 		$208K Sell
1,331
-443
-25% -$69.9K 0.1% 217
2014
Q1 		$270K Sell
1,774
-97
-5% -$15.4K 0.13% 171
2013
Q4 		$249K Sell
1,871
-24
-1% -$2.88K 0.13% 192
2013
Q3 		$220K Buy
+1,895
New +$208K 0.13% 182

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hilltop Holdings's ALXN Position: Q3 2014 in Review

Hilltop Holdings sold out of Alexion Pharmaceuticals (ALXN) in Q3 2014, closing a stake of 1,331 shares — an estimated $208K sold.

Hilltop Holdings first reported a position in ALXN in Q3 2013 and held it in 4 quarters. The position peaked at $270K in Q1 2014. 522 funds tracked by Wall St. Rank hold ALXN as of Q3 2014.

  • Hilltop Holdings reported no remaining Alexion Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Hilltop Holdings sold 1,331 Alexion Pharmaceuticals shares in Q3 2014, an estimated $208K.
  • Hilltop Holdings first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Hilltop Holdings's Alexion Pharmaceuticals position peaked at $270K in Q1 2014.
  • 522 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2014.

Based on Hilltop Holdings's 13F filing for Q3 2014, filed 14 Nov 2014.